Evidence map›Paper›PMID 42043215›Full record

ArticleViruses2026

Codon Usage Bias Variation and Evolutionary Signatures of Epstein-Barr Virus in Distinct Epithelial Cancers.

Xiaoqian Li, Xianyang Huang, Wan-Ting Li, Guy Baele, Liyuan Liu, Siyan Li, Jianjun Dai, Wan-Ting He

Abstract read
In one paragraph

Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoqian LiSchool of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.ORCID 0009-0008-6684-3699
Xianyang HuangSchool of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.ORCID 0009-0008-1928-1099
Wan-Ting LiSchool of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Guy BaeleDepartment of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-1915-7732
Liyuan LiuSchool of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Siyan LiSchool of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Jianjun DaiSchool of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.
Wan-Ting HeSchool of Pharmacy, China Pharmaceutical University, Nanjing 211198, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EBV genomic variation has been shown to contribute to the development of certain EBV-associated cancers. While EBV genomic variation has been extensively studied at the nucleotide level, it remains unclear how synonymous codon usage contributes to viral adaptation across epithelial cancer contexts. Here, we analyzed 1148 EBV genomes with annotated tumor origins to investigate genome-wide genetic differentiation and codon usage patterns of 13 core genes across NPC- and GC-associated viruses and EBV types. SNP-based analyses revealed partial genetic separation between NPC-EBV and GC-EBV, characterized by both rare GC-associated risk variants and common protective haplotypes. Codon usage patterns, however, showed strong gene-specific structure:

Indexed as

Codon UsageHerpesvirus 4, HumanNasopharyngeal CarcinomaNasopharyngeal NeoplasmsStomach NeoplasmsBase CompositionCodonGenome, ViralGenome-Wide Association StudyHumansPolymorphism, Single NucleotidePrincipal Component AnalysisCodoncodon usage patternEpstein–Barr virusgastric cancersnasopharyngeal carcinoma

Identifiers

PMID42043215
PMCPMC13119708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.